The results of established colitis treatment showed that the neutralization of TNF-α by the antibody generated a reduction in CD68 and myeloperoxidase (MPO) markers, indicating a reduction in macrophages and neutrophils in the colon tissue. This evidence concerns the gene CD68 and colitis.